search
Back to results

LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser (FS200)

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
FS200 femtosecond laser LASIK
IntraLase femtosecond laser LASIK
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients with ametropia (Spherical, spherocylindrical, presbyopic) suitable for treatment by LASIK, including different target refractions (Plano or Monovision).

Exclusion Criteria:

  • Patients unsuitable for LASIK procedure because of an estimated residual stromal bed < 300 microns after calculation of the ablation (Corneal thickness - flap thickness - simulated stromal ablation for the desired correction).
  • Patients unsuitable for LASIK due suspicious topography for ectasia, form frust keratoconus or unstable ( more than 0.50 diopter change in sphere or cylinder in the last year) refraction.
  • Patients with amblyopia or any eye disease that might limit the visual recovery.
  • Patients younger than 18 years old.

Sites / Locations

  • Cleveland Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

FS200 femtosecond laser LASIK

IntraLase femtosecond laser LASIK

Arm Description

LASIK flap created with an FS200 femtosecond laser system

LASIK flap created with an IntraLase femtosecond laser system

Outcomes

Primary Outcome Measures

Evaluation of LASIK Flap Thickness
Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.

Secondary Outcome Measures

Full Information

First Posted
December 16, 2013
Last Updated
February 22, 2018
Sponsor
The Cleveland Clinic
Collaborators
Alcon Research
search

1. Study Identification

Unique Protocol Identification Number
NCT02060461
Brief Title
LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser
Acronym
FS200
Official Title
LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser: 3 Months Follow-up of Initial US Clinical Series
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Cleveland Clinic
Collaborators
Alcon Research

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to evaluate the visual outcome, accuracy, predictability and complications of LASIK flap creation using the Alcon Wavelight FS200 Femtosecond laser and compare these results to those obtained using current IntraLase FS60 Femtosecond laser. The primary outcome to be evaluated is the flap thickness accuracy.
Detailed Description
Laser in situ keratomileusis (LASIK) is a method for treating myopia, hyperopia and astigmatism. In LASIK, the cornea is reshaped to focus images more clearly on the retina without the aid of glasses or contact lenses. LASIK involves two steps: creation of a corneal flap, which can be performed by a mechanical microkeratome or a femtosecond laser, and reshaping of the cornea by another laser, an excimer laser. The accuracy of the LASIK flap thickness is a key safety consideration to reduce the likelihood of complications following LASIK. Femtosecond laser technology has significantly improved the predictability of LASIK flap dimensions while supporting similar visual acuity results. The Alcon FS200 femtosecond laser is approved for human use by the United States Food and Drug Administration and was recently released in the US market. This study will directly compare outcomes of LASIK performed with this newer laser to those performed with the AMO IntraLase femtosecond laser.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Contralateral eye study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
FS200 femtosecond laser LASIK
Arm Type
Experimental
Arm Description
LASIK flap created with an FS200 femtosecond laser system
Arm Title
IntraLase femtosecond laser LASIK
Arm Type
Experimental
Arm Description
LASIK flap created with an IntraLase femtosecond laser system
Intervention Type
Device
Intervention Name(s)
FS200 femtosecond laser LASIK
Other Intervention Name(s)
Alcon FS200 femtosecond laser
Intervention Type
Device
Intervention Name(s)
IntraLase femtosecond laser LASIK
Other Intervention Name(s)
AMO IntraLase femtosecond laser
Primary Outcome Measure Information:
Title
Evaluation of LASIK Flap Thickness
Description
Central LASIK flap thickness for each femtosecond laser. Each treatment was set for a 110 micrometer thick flap.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients with ametropia (Spherical, spherocylindrical, presbyopic) suitable for treatment by LASIK, including different target refractions (Plano or Monovision). Exclusion Criteria: Patients unsuitable for LASIK procedure because of an estimated residual stromal bed < 300 microns after calculation of the ablation (Corneal thickness - flap thickness - simulated stromal ablation for the desired correction). Patients unsuitable for LASIK due suspicious topography for ectasia, form frust keratoconus or unstable ( more than 0.50 diopter change in sphere or cylinder in the last year) refraction. Patients with amblyopia or any eye disease that might limit the visual recovery. Patients younger than 18 years old.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William J Dupps, MD, PhD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24792107
Citation
Rocha KM, Krueger RR. Spectral-domain optical coherence tomography epithelial and flap thickness mapping in femtosecond laser-assisted in situ keratomileusis. Am J Ophthalmol. 2014 Aug;158(2):293-301.e1. doi: 10.1016/j.ajo.2014.04.012. Epub 2014 Apr 30.
Results Reference
result

Learn more about this trial

LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser

We'll reach out to this number within 24 hrs